Career history of John Harlan
Former positions of John Harlan
| Companies | Position | Start | End |
|---|---|---|---|
University of Washington
 University of Washington Other Consumer ServicesConsumer Services University of Washington functions as a College/University. The company is headquartered in Seattle, WA. | Corporate Officer/Principal | 2003-12-31 | 2003-12-31 |
ZymoGenetics, Inc.
 ZymoGenetics, Inc. Pharmaceuticals: MajorHealth Technology ZymoGenetics, Inc. develops protein based drugs. It focuses on the discovery, development, manufacture, and commercialization of therapeutic proteins for the treatment of human diseases, including homeostasis, inflammatory and autoimmune diseases, cancer, and viral infections. The company was founded by Earl W. Davie, Benjamin D. Hall and Michael Smith in 1981 and is headquartered in Seattle, WA. | Director/Board Member | - | - |
| Cytel Corp. | Director/Board Member | - | - |
CisThera, Inc.
 CisThera, Inc. Pharmaceuticals: MajorHealth Technology CisThera, Inc. operates as a biopharmaceutical company. It develops therapeutics to treat cancer, autoimmune diseases, as well as chronic kidney and liver diseases. The company was founded by John Harlan and is headquartered in Kirkland, WA. | Founder | - | - |
Statistics
International
| United States | 5 |
Operational
| Director/Board Member | 2 |
| Founder | 1 |
| Corporate Officer/Principal | 1 |
Sectoral
| Health Technology | 3 |
| Consumer Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Private companies | 3 |
|---|---|
CisThera, Inc.
CisThera, Inc. Pharmaceuticals: MajorHealth Technology CisThera, Inc. operates as a biopharmaceutical company. It develops therapeutics to treat cancer, autoimmune diseases, as well as chronic kidney and liver diseases. The company was founded by John Harlan and is headquartered in Kirkland, WA. | Health Technology |
| Cytel Corp. | |
ZymoGenetics, Inc.
ZymoGenetics, Inc. Pharmaceuticals: MajorHealth Technology ZymoGenetics, Inc. develops protein based drugs. It focuses on the discovery, development, manufacture, and commercialization of therapeutic proteins for the treatment of human diseases, including homeostasis, inflammatory and autoimmune diseases, cancer, and viral infections. The company was founded by Earl W. Davie, Benjamin D. Hall and Michael Smith in 1981 and is headquartered in Seattle, WA. | Health Technology |
- Stock Market
- Insiders
- John Harlan
- Experience
